Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
03/2013
03/14/2013WO2013034682A1 Vaccine based on staphylococcal superantigen- line 3 protein (ssl3)
03/14/2013WO2013034664A1 Bioconjugate vaccines made in prokaryotic cells
03/14/2013WO2013034660A1 Anti-siglec-15 antibodies and uses thereof
03/14/2013WO2013034069A1 Recombinant influenza virus highly expressing ha protein and preparation method and use thereof
03/14/2013WO2013023162A3 Anti-muc1 antibodies for cancer diagnostics
03/14/2013WO2013013075A3 Peptides shared among lethal cancers and therapeutic compositions comprising said peptides
03/14/2013WO2013012875A3 Bacterial rnas as vaccine adjuvants
03/14/2013WO2013011184A3 Chimeric molecule useful in immunotherapy for leishmaniasis, which includes a fragment of the pfr1 protein of leishmania infantum with specific immunodominant epitopes
03/14/2013WO2013011179A3 Recombinant vectors based on the modified vaccinia ankara (mva) virus, with deletion in the c6l gene, as vaccines against hiv/aids and other diseases
03/14/2013WO2013005164A3 Cancer antigen
03/14/2013WO2013001285A3 Fmdv vp1 peptides
03/14/2013WO2012178160A3 Materials and methods for modulating immune responses
03/14/2013WO2012174455A3 Group a streptococcus multivalent vaccine
03/14/2013WO2012153186A3 Monoclonal antibodies to epcam-icd and methods for detecting epithelial cancer cells
03/14/2013WO2012149393A3 Tolerogenic synthetic nanocarriers for antigen-specific deletion of t effector cells
03/14/2013WO2012149356A3 Anti-cd40 antibodies and methods of use
03/14/2013WO2012149307A3 Synthetic long peptide (slp)-based vaccines
03/14/2013WO2012149282A3 Tolerogenic synthetic nanocarriers for generating cd8+regulatory t cells
03/14/2013WO2012149252A3 Tolerogenic synthetic nanocarriers
03/14/2013WO2012145183A3 Combinations of anti-4-1bb antibodies and adcc-inducing antibodies for the treatment of cancer
03/14/2013WO2012135177A3 Methods and compositions for cytomegalovirus il-10 protein
03/14/2013WO2012118903A3 Sclerostin and dkk-1 bispecific binding agents
03/14/2013WO2012115715A3 Compositions with enhanced immunogenicity and/or reduced reactogenicity and methods of use
03/14/2013WO2012061815A3 RABIES GLYCOPROTEIN VIRUS-LIKE PARTICLES (VLPs)
03/14/2013US20130067608 Colon cancer targets and uses thereof
03/14/2013US20130064886 Microtablets for Drug Delivery
03/14/2013US20130064881 Compositions and methods for treating prostate cancer
03/14/2013US20130064867 Nanoemulsion respiratory syncytial virus (rsv) subunit vaccine
03/14/2013US20130064860 Combination pharmaceutical composition and methods of theating genitourinary system disorders
03/14/2013US20130064857 Methods and materials for making and using vaccines
03/14/2013US20130064856 Universal tumor cell vaccine for anti cancer therapeutic and prophylactic utilization
03/14/2013US20130064855 Reprogramming immune environment in breast cancer via dendritic cells
03/14/2013US20130064854 Methods of treating allergies with substantially phenol-free carriers
03/14/2013US20130064853 Parasite vaccine
03/14/2013US20130064852 Vaccine against mycoplasma, hyopneumoniae, suitable for administration in the presence of maternally derived antibodies
03/14/2013US20130064851 Inactivated staphylococcal whole-cell vaccine
03/14/2013US20130064850 Using Modified Plasmids to Suppress Antibiotic Resistant Pathogens
03/14/2013US20130064849 Methods to treat and prevent cardiovascular disease using human papillomavirus vaccines
03/14/2013US20130064848 Heterochain aliphatic poly-n-oxide copolymers and vaccinating agents and drugs based thereon
03/14/2013US20130064846 Neisserial antigens
03/14/2013US20130064845 Bacterial vaccine components from staphylococcus aureus and uses thereof
03/14/2013US20130064844 Non-splicing variants of gp350/220
03/14/2013US20130064843 Identification of conserved peptide blocks in homologous polypeptides
03/14/2013US20130064842 Compositions and Methods for Detection of Antibodies Specific for Anaplasma phagocytophilum (Aph) and Anaplasma platys (Apl)
03/14/2013US20130064841 Immunogenic compositions against human progastrin peptides
03/14/2013US20130064840 Hjurp peptides and vaccines including the same
03/14/2013US20130064839 Method of rapidly producing improved vaccines for animals
03/14/2013US20130064838 Enhanced death receptor agonists
03/14/2013US20130064837 Integrin alpha-v beta8 neutralizing antibody
03/14/2013US20130064836 Compositions and Methods for Antibodies Targeting Complement Protein C5
03/14/2013US20130064835 Rage regulates rock activity in cardiovascular disease
03/14/2013US20130064834 Methods for treating hypercholesterolemia using antibodies to pcsk9
03/14/2013US20130064833 Monitoring and Modulating HGF/HGFR Activity
03/14/2013US20130064832 Notch inhibition in the treatment and prevention of a metabolic disease or disorder and cardiovascular complications thereof
03/14/2013US20130064831 Immunotherapeutic dosing regimens and combinations thereof
03/14/2013US20130064830 Antibodies Specific for Sclerostin and Methods for Increasing Bone Mineralization
03/14/2013US20130064829 Antibodies Specific for Sclerostin and Methods for Increasing Bone Mineralization
03/14/2013US20130064828 Chimeric Vaccine for Haemophilus Influenzae-Induced Disease
03/14/2013US20130064827 Il-17 homologous polypeptides and thereapeutic uses thereof
03/14/2013US20130064826 Anti-emr1 antibodies
03/14/2013US20130064825 Methods of treating or preventing cholesterol related disorders
03/14/2013US20130064824 Combination pharmaceutical composition and methods of treating diabetes and metabolic disorders
03/14/2013US20130064823 Compositions and methods of use for therapeutic low density lipoprotein - related protein 6 (lrp6) multivalent antibodies
03/14/2013US20130064822 Humanized anti-egfl7 antibodies and methods using same
03/14/2013US20130064821 Methods and compositions for treating prostate cancer
03/14/2013US20130064820 Methods and compositions for treating degos' disease
03/14/2013US20130064819 Biomarkers
03/14/2013US20130064818 Use of immunesuppressant receptor
03/14/2013US20130064817 Engineered anti-il-23r antibodies
03/14/2013US20130064816 TNF-alpha ANTAGONISTS AND METHOTREXATE IN THE TREATMENT OF TNF-MEDIATED DISEASE
03/14/2013US20130064815 Inducing apoptosis in quiescent cells
03/14/2013US20130064814 Antagonists of products of the hs.459642 unigene cluster for the inhibition of proliferation, development or differentiation of stem cells including cancer stem cells
03/14/2013US20130064813 Protein Belonging to the TNF Superfamily Involved in Signal Transduction, Nucleic Acids Encoding Same and Methods of Use Thereof
03/14/2013US20130064812 Combination therapies for hematologic malignancies
03/14/2013US20130064811 Methods to Enhance Cancer Treatment
03/14/2013US20130064810 Methods and Compositions for the Detection and Treatment of Cancer involving miRNAs and miRNA Inhibitors and Targets
03/14/2013US20130064809 Antimicrobial Composition and Uses Thereof
03/14/2013US20130064793 Compounds and pharmaceutical compositions for the treatment of viral infections
03/14/2013US20130064790 Peptides with the capacity to bind to interleukin-10 (il-10)
03/14/2013US20130064789 Hairy Cell Leukemia Biomarkers and Methods of Using Same
03/14/2013US20130064788 Il-17 family cytokine compositions and uses
03/14/2013US20130064787 Methods for Treatment of HIV and Other Infections Using a T Cell or Viral Activator and Anti-Retroviral Combination Therapy
03/14/2013US20130064786 siRNA HYDROGEL AND METHOD FOR MANUFACTURING THE SAME
03/14/2013US20130064774 Methods and compositions for maintenance of a functional wound
03/14/2013US20130064761 Methods for the treatment of tumors expressing TAT123 or naturally occurring variants thereof
03/14/2013US20130064760 Method for Treating Crohn's Disease By Administering An Anti-IL-12 Antibody
03/14/2013CA2848163A1 Nanoemulsion respiratory syncytial virus (rsv) subunit vaccine
03/14/2013CA2848121A1 Anti third party central memory t cells, methods of producing same and use of same in transplantation and disease treatment
03/14/2013CA2848117A1 Recombinant influenza virus highly expressing ha protein and preparation method and use thereof
03/14/2013CA2848074A1 Anti-siglec-15 antibodies and uses thereof
03/14/2013CA2847837A1 A pharmaceutical composition for treating cancer, comprising interferon alpha conjugate
03/14/2013CA2847621A1 Bioconjugate vaccines made in prokaryotic cells
03/14/2013CA2847245A1 Use of c-met protein for predicting the efficacy of anti-hepatocyte growth factor ("hgf") antibodies in esophageal and gastric cancer patients
03/14/2013CA2846870A1 A conditional replicating cytomegalovirus as a vaccine for cmv
03/14/2013CA2846667A1 Serpinf2-binding molecules and methods of use
03/14/2013CA2846372A1 Oncolytic herpes simplex virus and therapeutic uses thereof
03/14/2013CA2838289A1 Sustained release formulations for delivery of proteins to the eye and methods of preparing same
03/13/2013EP2567982A1 Antibody against carcinoembryonic antigen and uses thereof
03/13/2013EP2567981A2 Anti-glycoprotein VI SCFV fragment for treatment of thrombosis
03/13/2013EP2567980A1 Use of neutralizing prolactin receptor antibodies for inhibition of lactation
1 ... 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 ... 1823